Biotherapy after marrow transplantation and the use of hematopoietic growth factors.
Bianco
J A
JA
University of Washington School of Medicine, Seattle.
Appelbaum
F R
FR
D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007116:Immunization, Passive; D007155:Immunologic Factors / Q000627:therapeutic use*; D016219:Immunotherapy, Adoptive; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D013935:Thymic Factor, Circulating / Q000627:therapeutic use
D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D007376:Interleukin-2; D007372:Interferons; D013935:Thymic Factor, Circulating